Robert Perrillo, MD | Director-Transplant Hepatology Fellowship Program – Baylor
Robert Perrillo, MD, is the Director of the Transplant Hepatology Fellowship Program at Baylor University Medical Center in Dallas.
He chairs the Hepatitis B Special Interest Group (SIG) of the American Association for the Study of Liver Diseases (AASLD), which was launched in 2009. This is AASLD’s largest SIG, with approximately 150 members, including many who are distinguished international members.
Prior to joining the Hepatology Division at Baylor in 2006, Dr. Perrillo was Director of Academic Affairs, Section of Gastroenterology and Hepatology, at the Ochsner Clinic Foundation in New Orleans, and Clinical Professor of Medicine at Tulane University.
Dr. Perrillo is internationally recognized for his work on antiviral therapy of chronic hepatitis B. He is an opinion leader in this area and has been actively engaged in the treatment of hepatitis B since the early 1980s.
Ms Bryant is a Dallas based healthcare entrepreneur and business leader. She has served in various healthcare committees in Texas including Medicare committee, Pediatric committee as well as with Texas Home Health and Hospice association.
Consolata is the founder and owner of Professional Home Health in Euless Texas, Divine Hospice in Euless Texas, and Arms of comfort Home Health in Azle Texas.
Ms Bryant has a background in Medical-surgical Neurology case management and has been a registered Nurse (RN) in Texas for over 20 years.
Her expertise is in Home Health as Director of Investments and clinical Services. She resides with her family in Colleyville Texas.
Is an entrepreneur, a business leader and corporate America executive, he has developed successful business opportunities with governments, educational, research institutions and major corporations.
Doug also held various positions during more than 25 years with Johnson and Johnson. His final position with Johnson & Johnson was Director of Worldwide New Business Development.
His experience in technology evaluations, product channel development, Market needs analysis and implementation strategy, and acquisitions involved the US, Africa, Asia, Latin America and Europe. His involvement included HIV prevalence studies in South African townships. Mr. Washington also served as Executive Vice President for WaterHealth International whose mission was the reduction and prevention of disease through waterborne transmission in developing countries.
He was Executive Vice President of World water & Solar technologies a publicly traded US company where the mission was providing of electricity to more than 25 developing countries using large scale and utility scale solar installations. He formed Washington Power, LLC, to further provide electricity and sustainable sources of potable water and electricity to domestic and foreign markets.
Douglas holds a B.S. in chemistry from the University of Texas and received executive training from the Wharton School of Business and the Kellogg School of Management.
Mr. Eric-Vincent Guichard is currently the Chairman and Chief Executive Officer of GRAVITAS Capital Advisors, Inc as well as Homestrings.com.
Mr. Guichard advises global and sovereign institutional assets. He runs the Sovereign Solutions Practice which includes innovative macro solutions such as the Sovereign Debt Redemption Fund Ltd and the Pension Support Fund Ltd. In addition, Mr. Guichard has initiated and manages innovative Absolute Return Products such as the Tactical Allocation Fund LLC.
He received a 2009 Risk Innovator Award for Finance from Risk & Insurance Magazine. Prior to GRAVITAS Capital, Mr. Guichard was Portfolio Manager at the World Bank where he served as technical adviser to sovereign and multilateral institutions worldwide.
Mr. Guichard is a graduate of the University of Dakar Senegal, of Duquesne University in Pittsburgh and of the Harvard Business School where he earned his MBA (World Bank Scholar and Harvard Fellowship award).
Mr. Bayo Adeniyi is currently the Chief Executive Officer and co-founder of the BinghamShore Corporation which operates several technology start-ups in the social, local and mobile space. Some of these businesses focus entirely on the United States while others either focus on developed international markets or developing markets in Africa and Asia.
In addition, Mr. Adeniyi serves as a consultant to several healthcare organizations including a private mental health hospital as well as an independent pharmacy.
Before BinghamShore, Bayo was an Executive consultant with the Kaiser Permanente organization in the Mid-Atlantic region where he helped drive strategy and special projects in the pharmacy and clinical services departments.
Prior to that he was a management consultant with Booz&Company (formerly the commercial business of Booz Allen Hamilton) where he worked as a key part of small teams tackling major issues at a leading healthcare insurance company, a leading consumer packaged goods company, a luxury automotive manufacturer, and a Canadian oil sands company amongst others. Bayo’s early career was as a pharmacist where he worked in retail pharmacy as well as hospital pharmacy in the United States and United Kingdom respectively.
Bayo holds a first degree in pharmacy from the University of Ibadan, Nigeria and completed a certificate of study of patient safety failures in the healthcare environment at the Harvard Medical School. He also holds an MBA from the Kellogg School of Management at Northwestern University where he was the Editor of the school paper as well as a recipient of the Dean’s exceptional service award.
Alazar Dessie is an International Banking Executive and Financial Consultant with over twenty eight years of experience managing banking and financial institutions and directing international development projects and businesses. In addition to executive positions at commercial and investment banks in NYC, he has held senior positions with a financial regulatory body in the United States and with international financial institutions based in Europe, Africa, Asia and the Middle East.
Mr. Dessie is recognized for his deep technical credit knowledge, excellent communication skills, demonstrated leadership abilities and proven financial consulting expertise. He is capable of managing start-up operations, competent in credit workouts and proficient in negotiations with the highest echelon of government officials and business leaders. In addition to the banking industry, he has extensive experience in economic studies of developing countries, particularly in Africa and Asia.
Mr. Dessie served as President & General Manager of Generale Bank, NY where he oversaw the operation of a $60 Bn in assets and registered consecutive record earnings during his tenure. At the Federal Reserve Bank of New York, he served as Sr. EIC in the International Department and Vice President, Credit and Marketing at the Gulf Bank. He also held the positions of Executive Vice President at CBE and BoA and Vice President, at Continental Bank International. As a consultant he has directed international projects sponsored by USAID, ECA and UNDP. He has successfully structured and implemented several million-dollar deals and programs in various regions around the world. Mr. Dessie currently works as an independent consultant conducting various studies in development economics and international finance.
Mr. Dessie is a frequent featured speaker on finance and banking issues as well as on development economics. He has presented papers, lectured and addressed conferences sponsored by UNDP, ECA Loan Pricing, Asset Sales Inc., and the Addis Forum. He has served as a member of the Foreign Policy, World Council of Management, Board of Atlantic Union College, the New York Auxiliary Police and other nonprofit organization
Alazar Dessie holds BA from Brandeis University and MA, MALD, ABD in International Law and Development Economics from the Fletcher School of Law and Diplomacy at Tufts with the cooperation of Harvard University. He is married and father of two.
Dr. Reid Jilek
Dr. Jilek has advanced degrees in the medical and life science and engineering disciplines. He was both a Presidential Fellow and a White House Fellow Candidate. He has published over 40 papers in national and international peer–reviewed scientific journals.
After completing his National Library of Medicine Post-Doctoral developing computer and mathematical models for Malaria, at the University of Virginia Medical Center, he decided to utilize his medical and scientific background in a business development capacity by acting as a VP of Business Development for private and public companies and a research institute.
Dr. Jilek has developed in excess of 8,000 professional contacts worldwide in the healthcare industry and investment world, to include: therapeutics, diagnostics, vaccines, gene therapy, medical devices, preclinical and clinical contract research organizations, nutraceuticals, generics, telemedicine, botanical, and biotech products, as well as the venture capital and investment banking industries. Additionally, Dr. Jilek has developed over 2,000 contacts in virtually every industry, to include, but not limited to: petroleum industry, medical tourism, tobacco industry, personal care products, bio fuels, mining, forestry, hospital development, alternative energy, food industry, fisheries, hydroponics, aquaculture, aquaphotonics, aviation, and recreation.
He was a founding member of Frederick Research Center and of Asia Pacific Alliance Company. He has served on the Board of Directors, Scientific or Medical Advisory Boards, or Advisory Boards for more than 40 private and public companies since 1990, in the US, Canada, Mexico, Japan, Taiwan, China, Portugal, Moscow, Israel and Germany. He has also served as the CEO of four companies.
Professor Mengech is a Professor of Psychiatry at Moi University, School of Medicine and the immediate former Chief Executive Officer (Director) of Moi Teaching and Referral Hospital. He is also the founder Dean of Moi University School of Medicine (previously Faculty of Health Sciences) and School of Public Health. He is a well known figure in research and has published over twenty (20) various research articles as well as conference papers. He also has considerable teaching experience in Psychiatry and Psycho-Pharmacology.
Mengech has contributed significantly to the fight against HIV/AIDS through AMPATH, a programme which he started together with Prof. Mamlin of Indiana University, USA and Prof. Khwa Otsyula, former Dean, Moi University School of Medicine. Today, AMPATH is one of the most successful and comprehensive HIV/AIDS programme in the world, a programme that has also expanded to include Primary Health Care activities in the Western Kenya region and nominated twice for the Nobel Peace Prize in 2007 and 2010 respectively.
He is a member of the Psychiatric Association of Kenya and has held various positions as Chairman and Board member of various health bodies and institutions of higher education in Kenya. He has also served as a Member of Moi University Council for 9 years and as a member of the Commission for Higher Education for 5 years.
In addition, Prof. Mengech has been a consultant to various organizations including AFCORP Investments (Pty) Ltd, AMPATH, Global Fund Malaria, MTRH, EDULINK Kenya, Brazaville, Advisor to WHO director on matters of research and development, Namibian government on establishment of Medical Schools, Alcoholics Anonymous, Sunderland, England, United Kingdom, Psychiatrist, South Shields General Hospital, South Tyneside, England, United Kingdom and most recently consultant to Nandi County Government in the development of County Intergrated Development Plan (CIDP) 2013/2015.
Taj is a member of the Licensing Executive Society, an Associate member of the Chartered Institute of Patent Attorneys and a member of PraxisUnico. Taj has led license deals on technologies as diverse as analysis software, vaccine technologies, protein & nucleic acid therapeutics, receptor drug targets, life science reagents, instrumentation, industrial enzymes and diagnostic components.
Following an academic career in both the UK and USA, during which Taj was a primary investigator on a number of grants from the National Cancer Institutes, he joined Isis Innovation in Oxford. After 3 years he was recruited to support the creation of a similar enterprise servicing the Ministry of Defence’s research facility at Porton Down (the Defence Science & Technology Laboratory). Taj’s responsibility was for writing and delivering the internal engagement plans and the relationship management across the thirteen Departments with specific responsibility for the commercialisation of IP assets arising from the Biomedical and Detection Departments amongst others.
Taj has a first degree in Applied Chemistry (covering synthetic organic chemistry, bioprocess technology and computing) from what is now Hertfordshire University; a Masters in Industrial Biotechnology (covering genetic engineering, waste water management and chemical engineering) from The University of Newcastle, and a Doctorate of Philosophy in Biochemistry (covering glycobiology, immunology, structural & analytical biochemistry) from The University of Oxford.
Dr. Moses Mwangi
Was for the last 16 years until 2012 the regional director for Sanofi Pasteur overseeing nine countries in Eastern Africa.
In that capacity , he was involved in most of the pioneer Hepatitis B neonatal vaccination programs in the region and related policies.
He is a graduate of the prestigious Alliance High school and the University of Nairobi Pharmacy School. Dr Mwangi also has an MBA from Moi University.
Moses is a founding member of Pharmaceutical Development trust. He also previously served as the executive chairman for Kenya Association of Pharmaceutical Industries (KAPI) as well as being a board member of Kenya Medical Supplies Agency (KEMSA). In the just concluded Kenyan elections , Dr Mwangi ran as a candidate for Governor.
Judd Walson is an Associate Professor, Departments of Global Health, Medicine (Infectious Disease), and Pediatrics at the University of Washington. He is also the Co-Director of the Strategic Analysis, Research and Training Program (START) at the campus.
He is also a Senior Research Fellow at the Division of Infectious Disease at the University of Washington and a graduate of both Duke and Tufts Universities.
Bonaventure joined the pharmaceutical/biotech industry over 20 years ago and has held a variety of sales and Marketing roles in Kenya, the UK, US and Canada, including working in global commercial strategy roles in Tropical Medicine, Oncology, Cardiovascular and Neuroscience disease fields.
Bonaventure’s interest in Hepatitis started when in the 90’s, he worked closely with the Ministry of Health in Kenya to develop a communications strategy to facilitate awareness of neonatal vaccination to prevent polio as well as helped increase the awareness of Hepatitis B. This initiative was the precursor for the introduction of the hepatitis antigen into neonatal vaccination in Kenya several years later. While at SmithKline Beecham, he also led in the development of a global philanthropic community partnership program – PHASE (Personal Hygiene and Sanitation Education) in addition to serving on a WHO antimalarial drug development team.
In addition to a series of international commercial roles at SmithKline Beecham and GlaxoSmithKline where Bonaventure last served as Director Global Commercial Strategy based in Research Triangle Park, North Carolina, as well, he held a commercial development role at CSL Behring and General Manager for Canada.
Bonaventure has an honors degree in Biochemistry and Zoology from the University of Nairobi and a Master of Business Administration from the United States International University – Africa (USIU-A).